1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United Kingdom >
  6. AstraZeneca >
  7. M&A

AstraZeneca Mergers & Acquisitions

AstraZeneca M&A Summary

AstraZeneca has acquired 25 companies, including 12 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 11 assets.

AstraZeneca’s largest acquisition to date was in 2020, when it acquired Alexion Pharmaceuticals for $39.0B. It’s largest disclosed sale occurred in 2016, when it sold AstraZeneca - Small Molecule Anti-Infective Business to Pfizer for $550M. AstraZeneca has acquired in 8 different US states, and 9 countries. The Company’s most targeted sectors include life science (92%) and information technology (5%).

M&A Summary

  • M&A Total Activity34
    • M&A Buy Activity23
    • M&A Sell Activity11
  • Total Sectors Invested 3
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 22

AstraZeneca

AstraZeneca Plc

1 Francis Crick Avenue Cambridge Biomedical Campus,
Cambridge, CB2 0AA
United Kingdom,
+44 20 3749 5000
www.astrazeneca.com

All (34) Buy (23) Sell (11)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-03-17 EsoBiotec · Life Science
Mont-Saint-Guibert, Belgium · www.esobiotec.com

EsoBiotec is a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. By engineering immune cells directly within the patient’s body, the company is eliminating the barriers of traditional cell therapies and unlocking new possibilities for oncology and immune-mediated diseases. Its proprietary ENaBL platform redefines adoptive cell therapy, enabling single IV, off-the-shelf treatments that reduce costs, improve patient experience, eliminate the need for immune cell depletion and have the potential to improve efficacy and safety through advanced lentiviral vector technology. EsoBiotec is based in Mont-Saint-Guibert, Belgium.

1,000 Add-on Acquisition

AstraZeneca

-

Try Mergr Free — See This and 221,316+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal